Relevant bibliographies by topics / Cardiology and Cardiovascular Medicine / Journal articles
To see the other types of publications on this topic, follow the link: Cardiology and Cardiovascular Medicine.

Journal articles on the topic 'Cardiology and Cardiovascular Medicine'

Author: Grafiati
Published: 9 July 2021
Last updated: 20 April 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Cardiology and Cardiovascular Medicine.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Escaned, Javier, Farouc A. Jaffer, Julinda Mehilli, and Roxana Mehran. "The year in cardiovascular medicine 2021: interventional cardiology." European Heart Journal 43, no. 5 (January 3, 2022): 377–86. http://dx.doi.org/10.1093/eurheartj/ehab884.

Full text
Abstract:
Abstract Since last year’s report in the European Heart Journal, we have witnessed substantial progress in all aspects of interventional cardiology. Of note, the practice of interventional cardiology took place amidst successive waves of the COVID-19 pandemic, which continues to be a major burden for all healthcare professionals around the globe. In our yearly review, we shall revisit the developments in percutaneous coronary intervention (PCI), structural heart interventions, and adjunctive pharmacotherapy.
APA, Harvard, Vancouver, ISO, and other styles
2

Balderrama, Priscila, Josué Souza Gleriano, Silvia Helena Henriques, Janise Braga Barros Ferreira, Larissa Roberta Alves, and Lucieli Dias Pedreschi Chaves. "Gestão em saúde: avaliação do acesso ao sistema regional." Revista de Enfermagem UFPE on line 13, no. 4 (April 19, 2019): 933. http://dx.doi.org/10.5205/1981-8963-v13i4a236966p933-942-2019.

Full text
Abstract:
RESUMOObjetivo: avaliar o acesso ao sistema regional de saúde a partir das ações de atenção aos agravos cardiovasculares. Método: trata-se de um estudo misto, descritivo. Coletaram-se dados a partir dos Sistemas de Informação Ambulatorial e Hospitalar do SUS, armazenados em planilhas Microsoft Excel e analisados utilizando-se estatística descritiva. Posteriormente, selecionaram-se 41 participanetes (gestores e reguladores) para responderem um questionário semiestruturado sobre acesso em cardiologia na rede regional. Optou-se pela Análise Temática de Conteúdo para análise dos dados qualitativos. Resultados: registrou-se o incremento da produção de consultas e exames, indicando a ampliação da oferta de serviços, a redução das internações clínicas e o crescimento das internações cirúrgicas em Cardiologia. Revelaram-se, em entrevistas, aspectos da organização da atenção no sistema regional que favorecem o acesso à atenção integral em Cardiologia. Conclusão: conclui-se que houve uma melhoria do acesso à atenção cardiovascular. Aponta-se que a coordenação do cuidado e a melhoria da resolubilidade da Atenção Básica favorecem o acesso à saúde, que também requer a implantação de estruturas sólidas de gestão, envolvendo planejamento, controle, regulação e avaliação. Descritores: Acesso aos Serviços de Saúde; Avaliação em Saúde; Doenças Cardiovasculares; Gestão em Saúde; Planejamento em Saúde; Regionalização.ABSTRACTObjective: to evaluate the access to the regional health system from the actions of attention to cardiovascular diseases. Method: this is a mixed, descriptive study. Data were collected from UHS Ambulatory and Hospital Information Systems, stored in Microsoft Excel spreadsheets and analyzed using descriptive statistics. Subsequently, 41 participanetes (managers and regulators) were selected to answer a semi-structured questionnaire about access in cardiology in the regional network. The Thematic Content Analysis was used to analyze the qualitative data. Results: there was an increase in the production of consultations and examinations, indicating the expansion of the service offer, the reduction of clinical hospitalizations and the increase of surgical hospitalizations in Cardiology. In interviews, aspects of the organization of care in the regional system that favor access to comprehensive care in Cardiology were revealed. Conclusion: it was concluded that there was an improvement in access to cardiovascular care. It is pointed out that the coordination of care and the improvement of the resolubility of Primary Care favor access to health, which also requires the implementation of solid management structures, involving planning, control, regulation and evaluation. Descriptors: Access to Health Services; Health Evaluation; Cardiovascular diseases; Health Management; Health Planning; Regionalization.RESUMENObjetivo: evaluar el acceso al sistema regional de salud a partir de las acciones de atención a los agravios cardiovasculares. Método: se trata de un estudio mixto, descriptivo. Se recolectó datos a partir de los Sistemas de Información Ambulatoria y Hospitalaria del SUS, almacenados en hojas de cálculo de Microsoft Excel y analizados utilizando estadística descriptiva. Posteriormente, se seleccionaron 41 participantes (gestores y reguladores) para responder un cuestionario semiestructurado sobre acceso en cardiología en la red regional. Se optó por el Análisis Temático de Contenido para el análisis de los datos cualitativos. Resultados: se registró el incremento de la producción de consultas y exámenes, indicando la ampliación de la oferta de servicios, la reducción de las internaciones clínicas y el crecimiento de las internaciones quirúrgicas en Cardiología. Se revelaron, en entrevistas, aspectos de la organización de la atención en el sistema regional que favorecen el acceso a la atención integral en Cardiología. Conclusion: se concluye que hubo una mejora del acceso a la atención cardiovascular. Se señala que la coordinación del cuidado y la mejora de la resolución de la Atención Básica favorecen el acceso a la salud, que también requiere la implantación de estructuras sólidas de gestión, involucrando planificación, control, regulación y evaluación. Descriptores: Accesibilidad a los Servicios de Salud; Evaluación en Salud; Enfermedades Cardiovasculares; Gestión en Salud; Planificación en Salud; Regionalización.
APA, Harvard, Vancouver, ISO, and other styles
3

Dolgova, E. V., N. A. Bodunova, A. I. Khavkin, and M. M. Litvinova. "Utility of personalized medicine in cardiology practice." Voprosy praktičeskoj pediatrii 18, no. 2 (2023): 65–75. http://dx.doi.org/10.20953/1817-7646-2023-2-65-75.

Full text
Abstract:
Significant changes have taken place in cardiology over the past 15 years within the framework of a personalized approach to the management of patients with cardiovascular diseases. This review provides up-to-date information on the genetic aspects of the development of various cardiovascular diseases, including heart and vascular malformations, cardiomyopathy, cardiac arrhythmias, dyslipidemia, arterial hypertension, thrombosis, and some others. In the current paper cardiovascular pathologies are divided according to the etiological principle into the chromosomal, monogenic and polygenic diseases. The problems of introducing intensively developing genetic technologies and medical genetic counseling into the practice of cardiologists, as well as the appropriate and rational usage and interpretation of genetic tests, remain actual issue. The necessity of a multidisciplinary approach in the management of cardiological patients with close cooperation of a cardiologist and a clinical geneticist is shown. Key words: cardiogenetics, hereditary diseases, cardiology, cardiovascular diseases, chromosomal diseases, gene diseases, congenital heart defects, cardiomyopathy, cardiac arrhythmia, cardiomyopathy, arterial hypertension, thrombosis, personalized medicine, mutations, polymorphisms
APA, Harvard, Vancouver, ISO, and other styles
4

Escaned, Javier, Farouc A. Jaffer, Julinda Mehilli, and Roxana Mehran. "The year in cardiovascular medicine 2021: interventional cardiology." Cardiologia Croatica 17, no. 3-4 (April 2022): 59–72. http://dx.doi.org/10.15836/ccar2022.59.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Medrano-Lopez, Constancio, and Jean-Claude Fouron. "Fetal Cardiology, the Frontier of Pediatric Cardiovascular Medicine." Revista Española de Cardiología (English Edition) 65, no. 8 (August 2012): 700–704. http://dx.doi.org/10.1016/j.rec.2012.03.015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Shapiro, Michael D., David J. Maron, Pamela B. Morris, Mikhail Kosiborod, Pratik B. Sandesara, Salim S. Virani, Amit Khera, et al. "Preventive Cardiology as a Subspecialty of Cardiovascular Medicine." Journal of the American College of Cardiology 74, no. 15 (October 2019): 1926–42. http://dx.doi.org/10.1016/j.jacc.2019.08.1016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Lourida, Katerina G., and George E. Louridas. "Constraints in Clinical Cardiology and Personalized Medicine: Interrelated Concepts in Clinical Cardiology." Cardiogenetics 11, no. 2 (May 10, 2021): 50–67. http://dx.doi.org/10.3390/cardiogenetics11020007.

Full text
Abstract:
Systems biology is established as an integrative computational analysis methodology with practical and theoretical applications in clinical cardiology. The integration of genetic and molecular components of a disease produces interacting networks, modules and phenotypes with clinical applications in complex cardiovascular entities. With the holistic principle of systems biology, some of the features of complexity and natural progression of cardiac diseases are approached and explained. Two important interrelated holistic concepts of systems biology are described; the emerging field of personalized medicine and the constraint-based thinking with downward causation. Constraints in cardiovascular diseases embrace three scientific fields related to clinical cardiology: biological and medical constraints; constraints due to limitations of current technology; and constraints of general resources for better medical coverage. Systems healthcare and personalized medicine are connected to the related scientific fields of: ethics and legal status; data integration; taxonomic revisions; policy decisions; and organization of human genomic data.
APA, Harvard, Vancouver, ISO, and other styles
8

Sheth, Mohit. "INVASIVE CARDIOLOGY: CARDIOVASCULAR CLINIC." Chest 89, no. 3 (March 1986): 16. http://dx.doi.org/10.1016/s0012-3692(16)61863-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Mehta, Anurag, Devinder S. Dhindsa, and Pratik B. Sandesara. "Enhancing Preventive Cardiovascular Medicine Training During General Cardiology Fellowship." Journal of the American College of Cardiology 74, no. 12 (September 2019): 1637–41. http://dx.doi.org/10.1016/j.jacc.2019.08.008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Bauer, Adrian, Christoph Benk, Holger Thiele, Johann Bauersachs, Sven Dittrich, Ingo Dähnert, Uwe Schirmer, et al. "Qualification, knowledge, tasks and responsibilities of the clinical perfusionist in Germany." Interactive CardioVascular and Thoracic Surgery 30, no. 5 (February 7, 2020): 661–65. http://dx.doi.org/10.1093/icvts/ivaa005.

Full text
Abstract:
Abstract Consensus paper of the German Society of Cardiovascular Engineering, the German Society for Thoracic and Cardiovascular Surgery, the German Society of Cardiology, the German Society of Pediatric Cardiology, the German Society of Anesthesiology and Intensive Care Medicine, the German Interdisciplinary Association of Intensive Care Medicine and Emergency Medicine and the German Society of Medical Intensive Care and Emergency Medicine.
APA, Harvard, Vancouver, ISO, and other styles
11

Purwowiyoto, Sidhi Laksono, Novi Anggriyani, and Steven Philip Surya. "Lymphatic Disease in Cardiology: The Forgettable One." Cardiovascular and Cardiometabolic Journal (CCJ) 1, no. 2 (September 19, 2020): 77. http://dx.doi.org/10.20473/ccj.v1i2.2020.77-81.

Full text
Abstract:
Before molecular medicine era, the lymphatic system was not getting enough attention in medicine world, especially in cardiovascular medicine. Our knowledge about lymphatic system is far left behind compare to vascular system. Many believes lymphatic function is isolated in regulate interstitial fluid hemostasis, fat transport, and immune transport. In deep investigation in lymphatic function shows that alteration in lymphatic vessel could disrupt normal cardiovascular function. Moreover, optimal cardiac lymphatic condition after post-heart tissue injury could enhance tissue regeneration. That is why in modern medicine era preserving optimal lymphatic condition and treat abnormal lymphatic condition might be beneficial in cardiovascular medicine.
APA, Harvard, Vancouver, ISO, and other styles
12

Hiatt, William R. "Cardiovascular medicine." Journal of Vascular Surgery 22, no. 3 (September 1995): 348. http://dx.doi.org/10.1016/s0741-5214(95)70162-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Braunwald, Eugene. "Featuring: Eugene Braunwald." European Cardiology Review 14, no. 2 (July 11, 2019): 130–33. http://dx.doi.org/10.15420/ecr.2019.14.2.cm1.

Full text
Abstract:
In the Cardiology Masters section of European Cardiology Review, we bring you an insight into the career of a key contributor to the field of cardiology. In this issue, we feature Professor Eugene Braunwald, cardiovascular medicine specialist at Brigham and Women’s Hospital and distinguished Hersey Professor of Medicine at Harvard University, Boston, Massachusetts, US.
APA, Harvard, Vancouver, ISO, and other styles
14

Nicol, Edward D., Rienk Rienks, Gary Gray, Norbert J. Guettler, Olivier Manen, Thomas Syburra, Joanna L. d’Arcy, Dennis Bron, and Eddie D. Davenport. "An introduction to aviation cardiology." Heart 105, Suppl 1 (November 13, 2018): s3—s8. http://dx.doi.org/10.1136/heartjnl-2018-313019.

Full text
Abstract:
The management of cardiovascular disease (CVD) has evolved significantly in the last 20 years; however, the last major publication to address a consensus on the management of CVD in aircrew was published in 1999, following the second European Society of Cardiology conference of aviation cardiology experts. This article outlines an introduction to aviation cardiology and focuses on the broad aviation medicine considerations that are required to manage aircrew appropriately and optimally (both pilots and non-pilot aviation professionals). This and the other articles in this series are born out of a 3 year collaborative working group between international military aviation cardiologists and aviation medicine specialists, many of whom also work with and advise civil aviation authorities, as part of a North Atlantic Treaty Organization (NATO) led initiative to address the occupational ramifications of CVD in aircrew (HFM-251). This article describes the types of aircrew employed in the civil and military aviation profession in the 21st century; the types of aircraft and aviation environment that must be understood when managing aircrew with CVD; the regulatory bodies involved in aircrew licensing and the risk assessment processes that are used in aviation medicine to determine the suitability of aircrew to fly with medical (and specifically cardiovascular) disease; and the ethical, occupational and clinical tensions that exist when managing patients with CVD who are also professional aircrew.
APA, Harvard, Vancouver, ISO, and other styles
15

García-Zamora, Sebastián, and Laura Pulido. "Vaccines in cardiology, an underutilized strategy to reduce the residual cardiovascular risk." Archivos Peruanos de Cardiología y Cirugía Cardiovascular 5, no. 1 (March 1, 2024): 29–39. http://dx.doi.org/10.47487/apcyccv.v5i1.349.

Full text
Abstract:
Las enfermedades cardiovasculares representan la primera causa de muerte en adultos de todo el mundo. Desde hace décadas se ha documentado que las infecciones en general, y particularmente las que involucran el aparato respiratorio, incrementan el riesgo de eventos cardiovasculares, cerebrovasculares y la mortalidad por todas las causas. Los mecanismos por los que las infecciones incrementan los eventos cardiovasculares son complejos, e incluyen la activación del sistema inmune, la inflamación sistémica, estados de hipercoagulabilidad, activación del sistema simpático y el aumento de la demanda miocárdica de oxígeno. En las infecciones respiratorias se agrega la hipoxemia. Estos mecanismos se interrelacionan, generando disfunción endotelial y accidentes de placa, y/o depresión miocárdica e insuficiencia cardíaca. Estos mecanismos pueden producir eventos cardiovasculares de novo o descompensar patologías preexistentes. Existe evidencia contundente de que las vacunas contra influenza, neumococo, herpes-zoster, COVID-19 y virus sincicial respiratorio son seguras en personas con factores de riesgo cardiovascular o enfermedad cardiovascular establecida. Incluso, la vacuna contra influenza ha demostrado ser segura cuando se administra en el período agudo de un síndrome coronario agudo en individuos que reciben angioplastia. Además de esto, estas intervenciones reducen la incidencia de eventos cardiovasculares en personas con riesgo cardiovascular incrementado. Sin embargo, las tasas de vacunación son marcadamente subóptimas. En el presente manuscrito se revisa la evidencia de la relación entre infecciones y eventos cardiovasculares. Además, se examina el rol de las inmunizaciones como una herramienta para reducir estos eventos y disminuir el riesgo cardiovascular residual. Finalmente, se plantea la necesidad de optimizar las tasas de vacunación en personas con cardiopatías.
APA, Harvard, Vancouver, ISO, and other styles
16

de Lorgeril, Michel, and Patricia Salen. "Diet as preventive medicine in cardiology." Current Opinion in Cardiology 15, no. 5 (September 2000): 364–70. http://dx.doi.org/10.1097/00001573-200009000-00009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Harrison, Donald C. "Cost containment in medicine: Why cardiology?" American Journal of Cardiology 56, no. 5 (August 1985): 10C—15C. http://dx.doi.org/10.1016/s0002-9149(85)80003-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Chua, TSJ, and YL Chua. "Cardiovascular Medicine and Surgery in Singapore: The Next Lap." Annals of the Academy of Medicine, Singapore 33, no. 4 (July 15, 2004): 405–6. http://dx.doi.org/10.47102/annals-acadmedsg.v33n4p405.

Full text
Abstract:
Fourteen years ago, an editorial in the Annals announced the coming of age of cardiology in Singapore. Among the issues raised in that editorial were the impact of changing demographics and disease patterns, the importance of optimising resources, and the need for structured training and sub-specialisation.
APA, Harvard, Vancouver, ISO, and other styles
19

Qi, Chenglei, and Fang Jiang. "Study on the application of accountability nursing in cardiology department." E3S Web of Conferences 233 (2021): 02015. http://dx.doi.org/10.1051/e3sconf/202123302015.

Full text
Abstract:
With the progress of medical technology, the treatment ability of central vascular diseases in hospitals is getting stronger and stronger, which improves patients’ confidence in the treatment of diseases. In the department of cardiovascular medicine, in order to improve the effect of treatment and improve patients’ satisfaction with medical services, bedside responsibility system nursing can be adopted for patients during the treatment process, which can effectively improve the quality and effect of nursing in the department of cardiovascular medicine and speed up the recovery of patients. This article narrated what is department of cardiovascular medicine, still elaborated the nursing method of bedside responsibility system in department of cardiovascular medicine and application effect.
APA, Harvard, Vancouver, ISO, and other styles
20

Glasenapp, A., A. Hess, and J. T. Thackeray. "Molecular imaging in nuclear cardiology: Pathways to individual precision medicine." Journal of Nuclear Cardiology 27, no. 6 (September 6, 2020): 2195–201. http://dx.doi.org/10.1007/s12350-020-02319-6.

Full text
Abstract:
AbstractGrowth of molecular imaging bears potential to transform nuclear cardiology from a primarily diagnostic method to a precision medicine tool. Molecular targets amenable for imaging and therapeutic intervention are particularly promising to facilitate risk stratification, patient selection and exquisite guidance of novel therapies, and interrogation of systems-based interorgan communication. Non-invasive visualization of pathobiology provides valuable insights into the progression of disease and response to treatment. Specifically, inflammation, fibrosis, and neurohormonal signaling, central to the progression of cardiovascular disease and emerging therapeutic strategies, have been investigated by molecular imaging. As the number of radioligands grows, careful investigation of the binding properties and added-value of imaging should be prioritized to identify high-potential probes and facilitate translation to clinical applications. In this review, we discuss the current state of molecular imaging in cardiovascular medicine, and the challenges and opportunities ahead for cardiovascular molecular imaging to navigate the path from diagnosis to prognosis to personalized medicine.
APA, Harvard, Vancouver, ISO, and other styles
21

Vogel, John H. K., Steven F. Bolling, Rebecca B. Costello, Erminia M. Guarneri, Mitchell W. Krucoff, John C. Longhurst, Brian Olshansky, et al. "Integrating Complementary Medicine Into Cardiovascular Medicine." Journal of the American College of Cardiology 46, no. 1 (July 2005): 184–221. http://dx.doi.org/10.1016/j.jacc.2005.05.031.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Auseon, Alex J., Albert J. Kolibash, and Quinn Capers. "Successful Efforts to Increase Diversity in a Cardiology Fellowship Training Program." Journal of Graduate Medical Education 5, no. 3 (September 1, 2013): 481–85. http://dx.doi.org/10.4300/jgme-d-12-00307.1.

Full text
Abstract:
Abstract Background A large volume of literature has documented racial disparities in the delivery of cardiovascular care in the United States and that decreased access to procedures and undertreatment lead to worse outcomes. A lack of diversity among physicians is considered to be a major contributor. The fellowship training program in cardiovascular medicine at The Ohio State University Medical Center had never trained a fellow from a minority group underrepresented in medicine (URM) before 2007. Intervention In 2005, the fellowship made it a priority to recruit and match URM candidates in an effort to address the community's lack of diversity and disparities in cardiovascular care. Methods Program leaders revised the recruitment process, making diversity a high priority. Faculty met with members of diverse residency programs during visits to other institutions, the focus of interview day was changed to highlight mentorship, additional targeted postinterview communications reached out to highly competitive applicants, and a regular mentoring program was constructed to allow meaningful interaction with URM faculty and fellows. Results Since these changes were implemented, the program has successfully matched a URM fellow for 5 consecutive years. Such candidates currently make up 4 of 16 total trainees (25%) in the fellowship in cardiovascular medicine. Conclusions The cardiovascular medicine fellowship training program at The Ohio State University was able to revise recruitment to attract competitive URM applicants as part of a concerted effort. Other educational programs facing similar challenges may be able to learn from the university's experiences.
APA, Harvard, Vancouver, ISO, and other styles
23

Melo de Barros e Silva, Pedro Gabriel, Tiago Frigini, Renato Delascio Lopes, Bernardo Baptista da Cunha Lopes, Bernardo Baptista da Cunha Lopes, Ariane V. Scarlatelli Macedo, Bruno R. Nascimento, Valter Furlan, and Antonio Luiz P. Ribeiro. "INTELIGÊNCIA ARTIFICIAL NA TOMADA DE DECISÃO CLÍNICA EM MEDICINA CARDIOVASCULAR." Revista da Sociedade de Cardiologia do Estado de São Paulo 32, no. 1 (January 15, 2022): 160–70. http://dx.doi.org/10.29381/0103-8559/2022320160-70.

Full text
Abstract:
Assim como nas atividades cotidianas, a prática médica contemporânea gera uma enorme quantidade de dados que frequentemente não se traduzem em informações clinicamente úteis, uma vez que a capacidade intelectual humana apresenta limitações para lidar com o chamado big data . A inteligência artificial (IA) possibilita a elaboração e a aplicação de algoritmos capazes de simular a inteligência humana, entretanto, pro - cessando um enorme volume de dados em curto intervalo de tempo. As informações geradas pela IA permitem aperfeiçoar modelos de decisão nos diferentes domínios do conhecimento, inclusive a prática médica, em que ferramentas de IA aprimoram a toma- da de decisões, particularmente quanto às inferências de probabilidades relacionadas com diagnóstico e prognóstico. Na cardiologia, há diversas aplicações da IA, como na priorização e aprimoramento de análise de exames, telemonitoramento, detecção de fibrilação atrial, predição de eventos cardiovasculares a longo e curto prazo (por exemplo, em um protocolo de dor torácica), avaliação de doenças cardíacas estruturais, dentre outras. Embora a IA tenha um enorme potencial disruptivo, há aspectos desafiadores de implicações relacionadas com o avanço da IA na cardiologia. Há necessidade de vigilância contínua sobre o funcionamento dessas ferramentas, incluindo o respeito aos preceitos éticos vigentes. A formação do médico também deverá ser adaptada para que o futuro médico possa aplicar corretamente não apenas o conhecimento clínico prático individual, mas também a correta interpretação e aplicação de dados (relação médico-paciente-dados). O presente artigo aborda as principais definições de IA, suas aplicações na tomada de decisão cardiovascular e os limites atuais dessas ferramentas.
APA, Harvard, Vancouver, ISO, and other styles
24

Moisa, Stefana Maria, Alexandru Burlacu, Lacramioara Ionela Butnariu, Corina Maria Vasile, Crischentian Brinza, Elena Lia Spoiala, Alexandra Maștaleru, et al. "Nanotechnology Innovations in Pediatric Cardiology and Cardiovascular Medicine: A Comprehensive Review." Biomedicines 12, no. 1 (January 15, 2024): 185. http://dx.doi.org/10.3390/biomedicines12010185.

Full text
Abstract:
(1) Background: Nanomedicine, incorporating various nanoparticles and nanomaterials, offers significant potential in medical practice. Its clinical adoption, however, faces challenges like safety concerns, regulatory hurdles, and biocompatibility issues. Despite these, recent advancements have led to the approval of many nanotechnology-based products, including those for pediatric use. (2) Methods: Our approach included reviewing clinical, preclinical, and animal studies, as well as literature reviews from the past two decades and ongoing trials. (3) Results: Nanotechnology has introduced innovative solutions in cardiovascular care, particularly in managing myocardial ischemia. Key developments include drug-eluting stents, nitric oxide-releasing coatings, and the use of magnetic nanoparticles in cardiomyocyte transplantation. These advancements are pivotal for early detection and treatment. In cardiovascular imaging, nanotechnology enables noninvasive assessments. In pediatric cardiology, it holds promise in assisting the development of biological conduits, synthetic valves, and bioartificial grafts for congenital heart defects, and offers new treatments for conditions like dilated cardiomyopathy and pulmonary hypertension. (4) Conclusions: Nanomedicine presents groundbreaking solutions for cardiovascular diseases in both adults and children. It has the potential to transform cardiac care, from enhancing myocardial ischemia treatment and imaging techniques to addressing congenital heart issues. Further research and guideline development are crucial for optimizing its clinical application and revolutionizing patient care.
APA, Harvard, Vancouver, ISO, and other styles
25

Thompson, Craig A., and Stephen N. Oesterle. "Biointerventional cardiology: the future interface of interventional cardiovascular medicine and bioengineering." Vascular Medicine 7, no. 2 (May 2002): 135–40. http://dx.doi.org/10.1191/1358863x02vm417ra.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Conti, C. Richard. "President's page: The American College of cardiology and world cardiovascular medicine." Journal of the American College of Cardiology 14, no. 3 (September 1989): 809–10. http://dx.doi.org/10.1016/0735-1097(89)90130-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Prendergast, B. D. "HIV AND CARDIOVASCULAR MEDICINE." Heart 89, no. 7 (July 1, 2003): 793–800. http://dx.doi.org/10.1136/heart.89.7.793.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Shaikh, Aaron Ali, Deepak L. Bhatt, and Ankur Kalra. "Leadership in Cardiovascular Medicine." European Heart Journal 40, no. 18 (May 7, 2019): 1395–97. http://dx.doi.org/10.1093/eurheartj/ehz257.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Marzilli, Mario, Dragos Vinereanu, Gary Lopaschuk, Yundai Chen, Jamshed J. Dalal, Nicolas Danchin, El Etriby, et al. "Trimetazidine in cardiovascular medicine." International Journal of Cardiology 293 (October 2019): 39–44. http://dx.doi.org/10.1016/j.ijcard.2019.05.063.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Jeremy, Richmond W. "Essentials of cardiovascular medicine." Asia Pacific Heart Journal 7, no. 1 (May 1998): 67. http://dx.doi.org/10.1016/s1328-0163(98)90091-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Bravo-Jaimes, Katia, and Gladys P. Velarde. "Diversity in Cardiovascular Medicine." JACC: Case Reports 10 (March 2023): 101749. http://dx.doi.org/10.1016/j.jaccas.2023.101749.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Maack, Christoph. "Interfaces in cardiovascular medicine." Herz 49, no. 2 (March 2024): 91–94. http://dx.doi.org/10.1007/s00059-024-05238-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Boytsov, S. A., N. V. Pogosova, A. A. Ansheles, V. A. Badtieva, T. V. Balakhonova, O. L. Barbarash, Yu A. Vasyuk, et al. "Cardiovascular prevention 2022. Russian national guidelines." Russian Journal of Cardiology 28, no. 5 (April 30, 2023): 5452. http://dx.doi.org/10.15829/1560-4071-2023-5452.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Belenkov, Yu N., and M. V. Kozhevnikova. "Mobile health technologies in cardiology." Kardiologiia 62, no. 1 (January 31, 2022): 4–12. http://dx.doi.org/10.18087/cardio.2022.1.n1963.

Full text
Abstract:
Digital medicine is becoming an essential part of the healthcare system. The intense development of mobile technologies, the global coverage of mobile networks, and the growing attachment in the society to mobile devices have prompted the creation of mobile healthcare (mHealth). At present, mobile healthcare technologies have been tested in various cardiovascular diseases. Among the main tasks set for telemedicine, it is necessary to note improvements of general medical care, monitoring of patients’ condition, accuracy of clinical diagnoses, timely correction of therapy, and improvement of emergency care. Clinical studies are performed in parallel with active work in the field of informational technologies to provide safety of data storage and intellectual processing. Finally, despite the broad public support for the development of this area of medicine, the search continues for methods to improve patients’ compliance with the prescribed therapy. This article presents current information about the use of mHealth in cardiology, study results, prospects of mobile healthcare, and major difficulties in implementing projects in this area.
APA, Harvard, Vancouver, ISO, and other styles
35

Ray, Kausik K., Ulrich Laufs, Francesco Cosentino, Melvin D. Lobo, and Ulf Landmesser. "The year in cardiology: cardiovascular prevention." European Heart Journal 41, no. 11 (January 6, 2020): 1157–63. http://dx.doi.org/10.1093/eurheartj/ehz929.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Alistair, L. "Cardiovascular highlights from non-cardiology journals." Heart 96, no. 11 (May 17, 2010): 898–99. http://dx.doi.org/10.1136/hrt.2010.199976.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Alistair, L. "Cardiovascular highlights from non-cardiology journals." Heart 96, no. 12 (June 1, 2010): 992–93. http://dx.doi.org/10.1136/hrt.2010.199992.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Alistair, L. "Cardiovascular highlights from non-cardiology journals." Heart 96, no. 13 (June 28, 2010): 1078–79. http://dx.doi.org/10.1136/hrt.2010.201897.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Alistair, L. "Cardiovascular highlights from non-cardiology journals." Heart 96, no. 14 (July 1, 2010): 1162–63. http://dx.doi.org/10.1136/hrt.2010.201905.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Alistair, L. "Cardiovascular highlights from non-cardiology journals." Heart 96, no. 15 (July 16, 2010): 1252–53. http://dx.doi.org/10.1136/hrt.2010.204495.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Alistair, L. "Cardiovascular highlights from non-cardiology journals." Heart 96, no. 16 (July 21, 2010): 1331–32. http://dx.doi.org/10.1136/hrt.2010.204503.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Alistair, C. L. "Cardiovascular highlights from non-cardiology journals." Heart 96, no. 17 (August 26, 2010): 1425–26. http://dx.doi.org/10.1136/hrt.2010.208231.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Lindsay, A. C. "Cardiovascular highlights from non-cardiology journals." Heart 96, no. 18 (September 1, 2010): 1509–10. http://dx.doi.org/10.1136/hrt.2010.208249.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Lindsay, A. C. "Cardiovascular highlights from non-cardiology journals." Heart 96, no. 19 (September 13, 2010): 1601–2. http://dx.doi.org/10.1136/hrt.2010.209973.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Lindsay, A. C. "Cardiovascular highlights from non-cardiology journals." Heart 96, no. 20 (October 11, 2010): 1682–83. http://dx.doi.org/10.1136/hrt.2010.209981.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Lindsay, A. C. "Cardiovascular highlights from non-cardiology journals." Heart 96, no. 21 (October 18, 2010): 1778–79. http://dx.doi.org/10.1136/hrt.2010.212654.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Lindsay, A. "Cardiovascular highlights from non-cardiology journals." Heart 96, no. 22 (October 21, 2010): 1857–58. http://dx.doi.org/10.1136/hrt.2010.212662.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Lindsay, A. C. "Cardiovascular highlights from non-cardiology journals." Heart 96, no. 23 (November 9, 2010): 1946–47. http://dx.doi.org/10.1136/hrt.2010.215517.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Lindsay, A. C. "Cardiovascular highlights from non-cardiology journals." Heart 96, no. 24 (November 18, 2010): 2041–42. http://dx.doi.org/10.1136/hrt.2010.215525.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Lindsay, A. C. "Cardiovascular highlights from non-cardiology journals." Heart 97, no. 1 (December 10, 2010): 85. http://dx.doi.org/10.1136/hrt.2010.218016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Cardiology and Cardiovascular Medicine' for other source types:
Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography